Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP800683.RA7SFCWU5pb4Q_6lMrKaiCpr4SWR89to1pNPO1UA4DG3k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP800683.RA7SFCWU5pb4Q_6lMrKaiCpr4SWR89to1pNPO1UA4DG3k130_assertion type Assertion NP800683.RA7SFCWU5pb4Q_6lMrKaiCpr4SWR89to1pNPO1UA4DG3k130_head.
- NP800683.RA7SFCWU5pb4Q_6lMrKaiCpr4SWR89to1pNPO1UA4DG3k130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800683.RA7SFCWU5pb4Q_6lMrKaiCpr4SWR89to1pNPO1UA4DG3k130_provenance.
- NP800683.RA7SFCWU5pb4Q_6lMrKaiCpr4SWR89to1pNPO1UA4DG3k130_assertion evidence source_evidence_literature NP800683.RA7SFCWU5pb4Q_6lMrKaiCpr4SWR89to1pNPO1UA4DG3k130_provenance.
- NP800683.RA7SFCWU5pb4Q_6lMrKaiCpr4SWR89to1pNPO1UA4DG3k130_assertion SIO_000772 20237793 NP800683.RA7SFCWU5pb4Q_6lMrKaiCpr4SWR89to1pNPO1UA4DG3k130_provenance.
- NP800683.RA7SFCWU5pb4Q_6lMrKaiCpr4SWR89to1pNPO1UA4DG3k130_assertion wasDerivedFrom befree-2016 NP800683.RA7SFCWU5pb4Q_6lMrKaiCpr4SWR89to1pNPO1UA4DG3k130_provenance.
- NP800683.RA7SFCWU5pb4Q_6lMrKaiCpr4SWR89to1pNPO1UA4DG3k130_assertion wasGeneratedBy ECO_0000203 NP800683.RA7SFCWU5pb4Q_6lMrKaiCpr4SWR89to1pNPO1UA4DG3k130_provenance.